Allergan Stock - Buy Or Sell

: The Allergan division, now branded as Allergan Aesthetics , continues to lead the global medical aesthetics market with products like Botox.

: For the full year 2026, management has guided for net revenues of approximately $67 billion, representing 9.5% growth. Historical Acquisition Terms allergan stock buy or sell

As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020. : The Allergan division, now branded as Allergan

: Analysts are currently focused on AbbVie's ability to offset the loss of exclusivity for its flagship drug, Humira, through newer immunology drugs like Skyrizi and Rinvoq . : The Allergan division